Metraipolis › archive › dc_cdb5f296cbb7

Psychological and quality of life outcomes associated with multikinase inhibitors versus immune checkpoint inhibitors in advanced hepatocellular carcinoma — Europe PMC PMID:41680278

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41680278
DOI
10.1038/s41598-[numero omesso]-y
License (as archived)
solo-consultazione
Archived
2026-11-05T21:19:53.237Z
SHA-256 of the archived text
bbef6667df3d0bde0cc89f8dc2ee8d07cc85265bda200ebd1c0a09fe3c533ed2
Stable URL of this page
https://metraipolis.com/documento/dc_cdb5f296cbb7

How to cite

Psychological and quality of life outcomes associated with multikinase inhibitors versus immune checkpoint inhibitors in advanced hepatocellular carcinoma — Europe PMC PMID:41680278 — Europe PMC (en), https://europepmc.org/article/MED/41680278 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cdb5f296cbb7 (Metraipolis archive dc_cdb5f296cbb7, sha256 bbef6667df3d0bde0cc89f8dc2ee8d07cc85265bda200ebd1c0a09fe3c533ed2)
BibTeX
@misc{dccdb5f296cbb7,
  title = {Psychological and quality of life outcomes associated with multikinase inhibitors versus immune checkpoint inhibitors in advanced hepatocellular carcinoma — Europe PMC PMID:41680278},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41680278},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cdb5f296cbb7; sha256 bbef6667df3d0bde0cc89f8dc2ee8d07cc85265bda200ebd1c0a09fe3c533ed2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41680278. Agents can read the archived copy with the MCP tool read_document.